Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exercise-based Smoking Cessation Treatment for Adults With High Anxiety Sensitivity
NCT06053567Phase 3Recruiting
- Start
- Dec 2023
- Primary completion
- Mar 2029
- Countries
- 1
01
Overview
Phase 3, randomised trial in nicotine dependence (2 arms). Primary endpoint: 7-day point prevalence abstinence at week 30. Started Dec 2023; status: recruiting.
02
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT06053567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06053567.